Date: 4 November 2021 3:43am WAT
A child gets a malaria vaccination at Yala Sub-County hospital, in Yala October 7, 2021. - World Health Organization (WHO) approved using the malaria vaccine, Mosquirix, on children between 5-month to 5-year old in sub-Saharan Africa and other parts with moderate to high malaria transmission after the malaria vaccine implementation programme (MVIP) in Ghana, Kenya, and Malawi since 2019. (Photo by Brian Ongoro / AFP)
A child gets a malaria vaccination at Yala Sub-County hospital, in Yala October 7, 2021. - World Health Organization (WHO) approved using the malaria vaccine, Mosquirix, on children between 5-month to 5-year old in sub-Saharan Africa and other parts with moderate to high malaria transmission after the malaria vaccine implementation programme (MVIP) in Ghana, Kenya, and Malawi since 2019. (Photo by Brian Ongoro / AFP)
The kids, between three and 59 months old from 17 local councils, are to be administered seasonal malaria chemoprevention drugs.
[ad]
While flagging off the therapy yesterday in Damaturu, the Director for Immunisation and Disease Control, YPHMB, Dr. Umar Chiroma, disclosed that the anti-malarial therapy was approved and supported by WHO to save lives.
According to him, exercise can prevent children from contracting malaria.
[ad]
Subscribe to the Guardian today and never miss the stories that shape your Business
Follow Us on Google News
Follow Us on Google Discover